![]()
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Seminoma with extensive metastases to the right atrium
Constantin Marcu, Kristen Andresen, Richard Salzano, Thomas
Donohue
A 43-year-old Caucasian male presented with mild dyspnoea on
exertion 2 years after treatment for stage IB testicular seminoma. Chest
radiography demonstrated multiple, bilateral lung nodules. Computed tomographic
(CT) imaging showed pulmonary nodules and a filling defect, measuring 5×4
cm, in the right atrium extending through the atrial wall into the anterior
mediastinum (Figure 1AB).
PA=pulmonary artery; RA=right atrium; Ao=aorta.
No periaortic or intrathoracic adenopathy was demonstrated.
Percutaneous lung nodule biopsy was nondiagnostic. Mediastinotomy under
cardiopulmonary bypass was planned because of concerns of possible right
ventricular inflow obstruction from the right atrial mass. Presurgical coronary
angiography demonstrated normal coronary arteries and a large “tumour
blush” in the region of the right atrium (Figure 1CD).
An intraoperative transoesophageal echocardiogram (TOE)
showed a mobile echogenic structure in the right atrium extending through the
atrial wall, into the mediastinum (Figure 2ABC).
The specimen was excised from the anterior mediastinum and
recurrent seminoma was confirmed on pathology. Surgical debulking was not
indicated, and chemotherapy with cisplatin, bleomycin, and etoposide was
started. After one course of chemotherapy, a follow-up TOE revealed a ~50%
reduction in the right atrial mass size without further evidence of extracardiac
extension (Figure 3ABC).
The patient will undergo three additional courses
of the same chemotherapy regimen.
LA=left atrium; RV=right ventricle; RA=right atrium;
Ao=aorta.
RV=right ventricle; RA=right atrium; LA=left atrium;.
Ao=aorta.
Author information:
Constantin B Marcu, Consultant Cardiologist, Vrije University Medical Center,
Amsterdam, The Netherlands; Kristen M Andresen, Consultant Cardiologist,
Hospital of Saint Raphael – Yale University, New Haven, CT, USA; Richard
Salzano, Consultant Cardiothoracic Surgeon, Hospital of Saint Raphael –
Yale University, New Haven, CT, USA; Thomas J Donohue, Consultant Cardiologist,
Hospital of Saint Raphael – Yale University, New Haven, CT, USA
Correspondence:
Constantin B Marcu, MD, Vrije University Medical Center, Department of
Cardiology 6D 120, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Fax: +31 20 4442446; email: bogmarcu@pol.net
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |